# Rimegepant: UK patient leaflet, explained

Source: patient information leaflet for Vydura 75mg Oral Lyophilisate (licence PLPI457631452), approved by the MHRA. Leaflet dated 2026-11-13. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/53283ac4125d90dd2dfa60ec0c52a766cb02713c

Canonical page: https://pestle.health/uk/rimegepant

## What is rimegepant for?
VYDURA is used to treat and prevent migraine attacks in adults. It contains rimegepant, which blocks the activity of a substance in the body called calcitonin gene-related peptide (CGRP).

## Key facts
- It can stop an active migraine attack and can reduce the number of migraine attacks when taken preventively.
- The maximum dose is one 75 mg oral lyophilisate per day.
- Stop taking it and tell your doctor straight away if you have signs of an allergic reaction, which can occur several days after taking it.
- It is not for children and adolescents under 18 years of age.
- Some medicines should be avoided with VYDURA, and others mean you should not take it more than once every 48 hours.

## Who should not take rimegepant?
- if you are allergic to rimegepant or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- if you have severe liver problems
- if you have reduced kidney function or are on kidney dialysis
- not to be given to children and adolescents under 18 years of age because it has not yet been studied in this age group

## Side effects that need urgent help
- Signs of an allergic reaction, such as severe rash or shortness of breath (uncommon, may affect up to 1 in 100 people)
- Signs of a severe allergic reaction known as anaphylaxis, such as swelling of tongue, mouth or face, trouble swallowing or breathing, throat tightness, or hoarseness (uncommon, may affect up to 1 in 100 people)

## How common are the side effects?
### Common (Up to 1 in 10 people)
- Nausea

### Uncommon (Up to 1 in 100 people)
- Allergic reactions, including anaphylaxis

## Other medicines the leaflet mentions
- Tell your doctor or pharmacist about any other medicines you are taking, have recently taken or might take
- Medicines to avoid: itraconazole and clarithromycin (fungal or bacterial infections)
- Medicines to avoid: ritonavir and efavirenz (HIV infections)
- Medicines to avoid: bosentan (high blood pressure)
- Medicines to avoid: St. John's wort (herbal remedy for depression)
- Medicines to avoid: phenobarbital (epilepsy)
- Medicines to avoid: rifampicin (tuberculosis)
- Medicines to avoid: modafinil (narcolepsy)
- Do not take VYDURA more than once every 48 hours with fluconazole and erythromycin (fungal or bacterial infections)
- Do not take VYDURA more than once every 48 hours with diltiazem, quinidine and verapamil (abnormal heart rhythm, chest pain (angina) or high blood pressure)
- Do not take VYDURA more than once every 48 hours with cyclosporin (prevents organ rejection after a transplant)

## Pregnancy and breastfeeding
It is preferable to avoid VYDURA during pregnancy as its effects in pregnant women are not known, so ask your doctor or pharmacist for advice. If you are breast-feeding or planning to, talk to your doctor or pharmacist; you and your doctor should decide if you will use it.

## How to take it
- To prevent migraine, take one 75 mg oral lyophilisate every other day.
- To treat a migraine attack, take one 75 mg oral lyophilisate as needed, not more than once daily. The maximum daily dose is one per day.
- Use dry hands, peel back the foil of one blister and gently remove the oral lyophilisate without pushing it through the foil. Place it on or under the tongue where it will dissolve; no drink or water is needed.
- It can be taken with or without food or water. Do not store the oral lyophilisate outside the blister for future use.
- If you miss a preventive dose, take the next dose at the usual time. Do not take a double dose.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
